Atlas Capital Advisors Inc. Acquires Shares of 7,758 Regeneron Pharmaceuticals, Inc. $REGN
Atlas Capital Advisors Inc. acquired a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund acquired 7,758 shares of the biopharmaceutical company’s stock, valued at approximately $5,988,000. Other institutional investors and hedge funds have also added to or reduced their stakes in the […]
14 Jun 08:37 · The Markets Daily